BRPI0412239A - sistemas emulsificantes contendo derivados de azetidina - Google Patents

sistemas emulsificantes contendo derivados de azetidina

Info

Publication number
BRPI0412239A
BRPI0412239A BRPI0412239-9A BRPI0412239A BRPI0412239A BR PI0412239 A BRPI0412239 A BR PI0412239A BR PI0412239 A BRPI0412239 A BR PI0412239A BR PI0412239 A BRPI0412239 A BR PI0412239A
Authority
BR
Brazil
Prior art keywords
systems containing
emulsifying systems
azetidine derivatives
containing azetidine
derivatives
Prior art date
Application number
BRPI0412239-9A
Other languages
English (en)
Inventor
Sophie Cote
Maria-Teresa Peracchia
Valerie Bobineau
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of BRPI0412239A publication Critical patent/BRPI0412239A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"SISTEMAS EMULSIFICANTES CONTENDO DERIVADOS DE AZETIDINA". A presente invenção refere-se a novas formulações de derivados de azetidina para administração oral.
BRPI0412239-9A 2003-07-18 2004-07-08 sistemas emulsificantes contendo derivados de azetidina BRPI0412239A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03291797A EP1498123A1 (en) 2003-07-18 2003-07-18 Emulsifying systems containing azetidine derivatives
PCT/EP2004/008552 WO2005013972A1 (en) 2003-07-18 2004-07-08 Emulsifying systems containing azetidine derivatives

Publications (1)

Publication Number Publication Date
BRPI0412239A true BRPI0412239A (pt) 2006-09-12

Family

ID=33462260

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0412239-9A BRPI0412239A (pt) 2003-07-18 2004-07-08 sistemas emulsificantes contendo derivados de azetidina

Country Status (31)

Country Link
US (1) US20050037062A1 (pt)
EP (2) EP1498123A1 (pt)
JP (1) JP2009513559A (pt)
KR (1) KR20060040690A (pt)
CN (1) CN1822830A (pt)
AR (1) AR045912A1 (pt)
AU (1) AU2004262497A1 (pt)
BR (1) BRPI0412239A (pt)
CA (1) CA2532668A1 (pt)
CR (1) CR8178A (pt)
EC (1) ECSP066291A (pt)
GT (1) GT200400134A (pt)
HR (1) HRP20060021A2 (pt)
IL (1) IL173113A0 (pt)
MA (1) MA27921A1 (pt)
MX (1) MXPA06000478A (pt)
MY (1) MY142076A (pt)
NO (1) NO20060510L (pt)
NZ (1) NZ544707A (pt)
OA (1) OA13190A (pt)
PA (1) PA8606601A1 (pt)
PE (1) PE20050699A1 (pt)
RS (1) RS20050971A (pt)
RU (1) RU2348615C2 (pt)
SG (1) SG144140A1 (pt)
TN (1) TNSN06012A1 (pt)
TW (1) TW200522946A (pt)
UA (1) UA82539C2 (pt)
UY (1) UY28422A1 (pt)
WO (1) WO2005013972A1 (pt)
ZA (1) ZA200600489B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1498122A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Semi-solid systems containing azetidine derivatives
CA2626579A1 (en) * 2005-10-25 2007-05-03 Abbott Laboratories Formulation comprising a drug of low water solubility and method of use thereof
US20080103481A1 (en) * 2006-09-29 2008-05-01 Pluromed, Inc. Methods for Preventing Retropulsion of Concretions and Fragments During Lithotripsy
KR101493546B1 (ko) * 2007-08-21 2015-02-16 바실리어 파마슈티카 아게 항균 조성물
FR2923719B1 (fr) * 2007-11-15 2009-11-20 Sanofi Aventis Compositions pharmaceutiques a base de derives d'azetidine
IT1394400B1 (it) * 2009-02-25 2012-06-15 Neuroscienze Pharmaness S C Ar L Composizioni farmaceutiche
WO2016164770A1 (en) 2015-04-10 2016-10-13 Bioresponse, L.L.C. Self-emulsifying formulations of dim-related indoles
CN111759823B (zh) * 2015-09-17 2022-12-30 阿赖耶识（上海）生物技术有限公司 一种高稳定的非囊泡型纳米颗粒及其在治疗微生物感染中的应用
CN110913906A (zh) 2017-05-02 2020-03-24 默沙东公司 抗lag3抗体的制剂和抗lag3抗体与抗pd-1抗体的共制剂
JOP20190260A1 (ar) 2017-05-02 2019-10-31 Merck Sharp & Dohme صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها
US20240277615A1 (en) * 2021-06-11 2024-08-22 Universidade Da Beira Interior Self-emulsifying composition, production methods and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
JP2740153B2 (ja) * 1995-03-07 1998-04-15 エフ・ホフマン−ラ ロシユ アーゲー 混合ミセル
GB9600235D0 (en) * 1996-01-05 1996-03-06 Pfizer Ltd Therapeutic agents
US6355631B1 (en) * 2000-03-03 2002-03-12 Aventis Pharma S.A. Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
FR2814678B1 (fr) * 2000-10-04 2002-12-20 Aventis Pharma Sa Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite
FR2829027A1 (fr) * 2001-08-29 2003-03-07 Aventis Pharma Sa Association avec un antagoniste du recepteur cb1, les compositions pharmaceutiques les contenant et leur utilisation pour le traitement de la maladie de parkinson
FR2833842B1 (fr) * 2001-12-21 2004-02-13 Aventis Pharma Sa Compositions pharmaceutiques a base de derives d'azetidine

Also Published As

Publication number Publication date
UA82539C2 (en) 2008-04-25
RS20050971A (sr) 2008-06-05
JP2009513559A (ja) 2009-04-02
AR045912A1 (es) 2005-11-16
IL173113A0 (en) 2006-06-11
TNSN06012A1 (en) 2007-10-03
CN1822830A (zh) 2006-08-23
PE20050699A1 (es) 2005-09-15
NZ544707A (en) 2009-01-31
UY28422A1 (es) 2005-02-28
MA27921A1 (fr) 2006-06-01
AU2004262497A2 (en) 2005-02-17
PA8606601A1 (es) 2005-03-03
WO2005013972A1 (en) 2005-02-17
MXPA06000478A (es) 2006-04-05
TW200522946A (en) 2005-07-16
AU2004262497A1 (en) 2005-02-17
NO20060510L (no) 2006-01-31
OA13190A (en) 2006-12-13
GT200400134A (es) 2005-02-22
ZA200600489B (en) 2007-04-25
RU2348615C2 (ru) 2009-03-10
MY142076A (en) 2010-08-30
RU2006105000A (ru) 2006-07-10
HRP20060021A2 (en) 2006-02-28
CR8178A (es) 2007-12-04
EP1648441A1 (en) 2006-04-26
ECSP066291A (es) 2006-07-28
CA2532668A1 (en) 2005-02-17
KR20060040690A (ko) 2006-05-10
US20050037062A1 (en) 2005-02-17
EP1498123A1 (en) 2005-01-19
SG144140A1 (en) 2008-07-29

Similar Documents

Publication Publication Date Title
CO5590918A2 (es) Formulaciones
PA8595901A1 (es) "n-arilheterociclos sustituidos, procedimientos para su preparacion, y su empleo como medicamentos
BR0211972A (pt) Composição oftálmica
HN1999000066A (es) Formulaciones farmaceuticas
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
ATE303149T1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
SE0201544D0 (sv) Novel compounds and thier use
BRPI0408895A (pt) formulações de cladribina para administração oral e transmucosal aperfeiçoada
MXPA05006889A (es) Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.
BRPI0417950A (pt) composições farmacêuticas
ECSP066291A (es) Sistemas emulsionantes que contienen derivados de azetidina
BRPI0408848A (pt) formulações orais de cladribine
BRPI0412740A (pt) formulações auto-emulsifcantes e automicroemulsificantes para a administração oral de taxóides
MXPA06000636A (es) Formulaciones semi-solidas para la administracion oral de taxoides.
DE502004011919D1 (de) -trien-3-yl sulfamate
BRPI0412737A (pt) sistema semi-sólidos contendo derivados de azetidina
BRPI0409175A (pt) preparação farmacêutica oral para antagonistas de bombeamento de próton
NO20064808L (no) Orale matrixformuleringer med licarbazepin
BRPI0408209A (pt) novas composições
FR2861992B1 (fr) Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3-carboxamide.
HN2002000331A (es) Composiciones farmaceuticas de 5,7,14-triazatetra-ciclo (10.3.1.02,11.04,9)-hexadeca-2(11) 3,5,7,9-pentaeno

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.